Patents by Inventor Eric Sletten

Eric Sletten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230026870
    Abstract: The present invention relates to device for automated synthesis of oligo- and polysaccharides on a solid support.
    Type: Application
    Filed: November 4, 2020
    Publication date: January 26, 2023
    Inventors: Peter H. Seeberger, Jose Danglad Flores, Kim LE MAI HOANG, Alonso Pardo Vargas, Eric Sletten, Mario Salwiczek
  • Publication number: 20220395800
    Abstract: The present invention generally relates to automated synthesis technology, and more particularly, to a device and method for automated synthesis of oligo- and polysaccharides on a solid support. In particular the present invention relates to a device for automated synthesis of oligo- and polysaccharides on a solid support comprising a reaction vessel, a reagent storing component, a reagent delivery system, a cooling device for cooling reaction vessel, and a pre-cooling device for pre-cooling the reagents to be supplied.
    Type: Application
    Filed: November 4, 2020
    Publication date: December 15, 2022
    Inventors: Peter H. Seeberger, Jose Danglad Flores, Kim LE MAI HOANG, Alonso Pardo Vargas, Eric Sletten, Mario Salwiczek
  • Publication number: 20220387957
    Abstract: The present invention relates to a method for synthesizing oligo- and polysaccharides using microwave radiation, in particular to a method and a device for automated synthesis of oligo- and polysaccharides.
    Type: Application
    Filed: November 4, 2020
    Publication date: December 8, 2022
    Inventors: Peter H. Seeberger, Jose Danglad Flores, Kim Le Mai Hoang, Alonso Pardo Vargas, Eric Sletten, Mario Salwiczek
  • Publication number: 20210330693
    Abstract: Anti-heparanase compounds for the treatment of cancer are described. The anti-heparanase compounds are high affinity, synthetic glycopolymers that result in minimal anticoagulant activity. Stereoselective fluorinated forms of these compounds are also provided.
    Type: Application
    Filed: December 5, 2019
    Publication date: October 28, 2021
    Applicants: Wayne State University, Technion, Israel Institute of Technology, University of Iowa Research Foundation
    Inventors: Hien M. Nguyen, Ravi Sankar Loka, Eric Sletten, Israel Vlodavsky